Cure Alzheimer's Fund finances high-potential research, some of it in the “proof of concept” stage, which might not be funded initially by the National Institutes of Health or other funders. This “pump priming” is proving increasingly successful, as more of our early-stage grants are leveraged into more substantial and longer-term funding. Another indicator of success is the number of peer-reviewed papers that Cure Alzheimer’s Fund researchers have published,
and the number of times those papers have been cited by other investigators.
2013 grant recipients include*:
- Roberto Malinow, M.D., Ph.D., Synaptic Depression/PICK1 project, received NIH R01 grant
- Sam Gandy, M.D., Ph.D., Oligomer Consortium project, received two VA MERIT grants
- Sam Gandy, M.D., Ph.D., and Scott Noggle, Ph.D., Stem Cell Consortium project, received NIA R21 grant and NIA U01 grant
*As reported by Cure Alzheimer’s Fund-funded researchers.
NOTE: For a full listing of published papers supported by Cure Alzheimer’s Fund, see www.curealz.org.